Suppr超能文献

中东器官移植协会(MESOT)移植登记处。

Middle East Society for Organ Transplantation (MESOT) Transplant Registry.

作者信息

Masri Marwan A, Haberal Mehmet A, Shaheen Faissal A M, Stephan Antoine, Ghods Ahad J, Al-Rohani Muhamed, Mousawi Mustafa Al, Mohsin Nabil, Abdallah Taieb Ben, Bakr Adel, Rizvi Adibul Hasan

机构信息

Rizk Hospital, Lebanon.

出版信息

Exp Clin Transplant. 2004 Dec;2(2):217-20.

Abstract

During the seventies, sporadic renal transplants were performed in few MESOT-region countries, mainly Turkey, Iran, Egypt, and Lebanon. Since the introduction of cyclosporine in the early eighties, transplantation has become the preferred therapeutic modality for end-stage renal failure. In 1986, the Islamic theologians (Al Aloma) issued what became known as the Amman declaration, in which they accepted brain death and retrieval and transplantation of organs from living and cadaveric donors. Based on this and similar declarations, all Middle Eastern countries except Egypt passed laws that allow cadaveric transplantation and regulate live donations. Iran, Turkey, Saudi Arabia, Kuwait, Tunisia, Jordan, and Lebanon all have current active cadaveric programs and perform liver, heart, pancreas, and lung transplants. More than 5088 renal transplants/year are performed in the region with Iran leading with 1600. The cumulative number of renal transplant patients is now nearly 60,000. With a 2003 population of 600,682,175, the rate/million for renal transplantation in the MESOT region is a mere 9/million. Rates of renal transplantation range from 31/million in some countries to 0 in others. The major obstacle in establishing an accurate number of transplants is "tourist transplantation," in which the same transplanted patients are registered in different countries. Although cadaveric programs have been active for more than 10 years, live-related and nonrelated transplants account for nearly 85% of the total transplants. The data presented were collected from MESOT representatives in the region and from publications. For proper compilation of the registry, a format is being proposed that will be presented at the Congress for review and adaptation. Even with the limited resources in the region, immunosuppressive drugs for induction and maintenance therapy are available and are used. Costs for transplantation and immunosuppressive therapy are either totally or heavily supported by governmental agencies.

摘要

在七十年代,中东和北非地区(MESOT)的少数国家,主要是土耳其、伊朗、埃及和黎巴嫩,开展了零星的肾移植手术。自八十年代初引入环孢素以来,移植已成为终末期肾衰竭的首选治疗方式。1986年,伊斯兰神学家(Al Aloma)发表了后来被称为《安曼宣言》的声明,其中他们接受脑死亡以及从活体和尸体供体获取和移植器官。基于这一声明及类似声明,除埃及外的所有中东国家都通过了允许尸体移植并规范活体捐赠的法律。伊朗、土耳其、沙特阿拉伯、科威特、突尼斯、约旦和黎巴嫩目前都有活跃的尸体移植项目,并开展肝脏、心脏、胰腺和肺移植。该地区每年进行超过5088例肾移植手术,其中伊朗以1600例领先。肾移植患者的累计数量目前接近6万。2003年中东和北非地区人口为600,682,175,该地区肾移植的每百万人口发生率仅为9例。肾移植率在一些国家为每百万人口31例,而在其他国家则为0。确定准确移植数量的主要障碍是“游客移植”,即同一移植患者在不同国家登记。尽管尸体移植项目已经开展了十多年,但亲属活体和非亲属活体移植占总移植量的近85%。所呈现的数据是从该地区的中东和北非地区代表以及出版物中收集的。为了正确汇编登记册,正在提议一种格式,将在大会上展示以供审查和调整。即使该地区资源有限,诱导和维持治疗的免疫抑制药物也有供应并被使用。移植和免疫抑制治疗的费用全部或大部分由政府机构承担。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验